EICHOR
● Recruiting
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus · T2DM · Sponsor: Hanmi Pharmaceutical Company Limited
About this study
This study is a Phase 2 clinical trial to evaluate the efficacy, safety, and tolerability of HM15275 in subjects with type 2 diabetes mellitus over 36 weeks.
This description comes directly from the study's public registry record.
Talk to the study team
Pureun Nam · +82-2-410-9147 · pureun.nam@hanmi.co.kr
Hyeonho Choi · +82-2-410-9834 · hyeonho.choi@hanmi.co.kr
Always discuss trial participation with your own doctor first.
Locations (14)
| Desert Clinical Research | Mesa, Arizona, United States | Recruiting |
| Accel Research Sites - DeLand | DeLand, Florida, United States | Recruiting |
| Charter Research | Orlando, Florida, United States | Recruiting |
| AdventHealth Translational Research Institute | Orlando, Florida, United States | Not Yet Recruiting |
| Centricity Research IRT - DBA IACT Health Columbus Piedmont | Columbus, Georgia, United States | Recruiting |
| The South Bend Clinic | South Bend, Indiana, United States | Recruiting |
| Jefferson City Medical Center | Jefferson City, Missouri, United States | Recruiting |
| Clay Platte Family Medicine | Kansas City, Missouri, United States | Recruiting |
| Methodist Physicians Clinic | Fremont, Nebraska, United States | Recruiting |
| Santa Rosa Medical Centers of Nevada | Las Vegas, Nevada, United States | Recruiting |
| Lucas Research, Inc. | Morehead City, North Carolina, United States | Recruiting |
| Centricity Research Columbus | Columbus, Ohio, United States | Recruiting |
+ 2 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07527650